Physician

Scott Thomas Gauthreaux, M.D.

According to 2025 Medicare claims, Scott Gauthreaux, M.D. (NPI: 1710942065) practices ophthalmology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is ACADIANA RETINA CONSULTANTS, LLC (NPI: 1003920778; TIN: 050538463) and primary practice location at 70503-3038.

Gauthreaux's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 173,590 HCPCS/CPT codes, and received $1,598,881 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 921 prescription claims across 237 beneficiaries totaling $45,956 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 45 records totaling $1,220. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$810K$1.6M2015 Medicare payment: $1,201,369 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,363,252 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,444,986 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,619,618 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,595,654 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,430,396 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,440,571 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,392,044 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,478,300 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,598,881 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0596,970$1,201,369
20161,0467,463$1,363,252
20171,0117,597$1,444,986
20181,0358,453$1,619,618
20191,0279,070$1,595,654
20208897,970$1,430,396
20219778,735$1,440,571
20221,0039,117$1,392,044
202399033,294$1,478,300
2024919173,590$1,598,881

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$40K$80K2015 Drug cost: $46,148 (USD; Tot_Drug_Cst)2016 Drug cost: $43,351 (USD; Tot_Drug_Cst)2017 Drug cost: $57,203 (USD; Tot_Drug_Cst)2018 Drug cost: $70,070 (USD; Tot_Drug_Cst)2019 Drug cost: $73,055 (USD; Tot_Drug_Cst)2020 Drug cost: $74,189 (USD; Tot_Drug_Cst)2021 Drug cost: $76,577 (USD; Tot_Drug_Cst)2022 Drug cost: $80,166 (USD; Tot_Drug_Cst)2023 Drug cost: $61,322 (USD; Tot_Drug_Cst)2024 Drug cost: $45,956 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158570$46,148
2016148554$43,351
2017147531$57,203
2018160583$70,070
2019160668$73,055
2020185723$74,189
2021186753$76,577
2022200784$80,166
2023212759$61,322
2024237921$45,956

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more182182$116
67028Injection of drug into eye2671,020$90
92014Established patient complete exam of visual system7551,257$87
92012Established patient problem focused exam of visual system194306$63
92134Imaging of retina8732,236$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium431,021$6,535
Prednisolone AcetatePrednisolone Acetate1555,387$6,490
IlevroNepafenac11314$4,032
DifluprednateDifluprednate31860$3,195
MethazolamideMethazolamide12360$2,450

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$1,220Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Scott Thomas Gauthreaux, M.D.?

Tedicare shows public-source Medicare data for Scott Thomas Gauthreaux, M.D. (NPI 1710942065), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Thomas Gauthreaux, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott Thomas Gauthreaux, M.D.?

Scott Thomas Gauthreaux, M.D. is linked to ACADIANA RETINA CONSULTANTS, LLC (billing NPI 1003920778) in the available physician profile data.

Does Scott Thomas Gauthreaux, M.D. have Open Payments data?

Scott Thomas Gauthreaux, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.